AT
LinkedIn

Andrew Tochterman

Chief Commercial Officer

United States · 1 connection

Mainstay Medical

Not on Unlinked · Imported profile. Is this you? Claim it

About

Andrew Tochterman is the Chief Commercial Officer at Mainstay Medical. In this role, he is responsible for driving commercial excellence, and scalable growth of the company's flagship product, ReActiv8 - a restorative neurostimulation innovation for patients with Mechanical Chronic Low Back Pain.

Experience

Chief Commercial OfficerMainstay Medical
Nov 2024
Vice President and General Manager, CoronaryPhilips
Apr 2019 to Oct 2024
Coronary Segment LeaderPhilips
Jun 2016 to Apr 2019
Senior Director, FM Segment LeaderVolcano Corporation
Jan 2015 to Jun 2016
Director of New Product Planning, FM Business UnitVolcano Corporation
Sep 2013 to Jan 2015
Associate Director, Diagnostic AngiographyVolcano Corporation
Nov 2012 to Sep 2013
Territory Manager of Coronary SalesAbbott
Feb 2010 to Nov 2012
Manager of Clinical Marketing and Strategic Drug Eluting Stent MarketingAbbott
Oct 2007 to Feb 2010
Product Manager of Global Drug Eluting Stents and Guide Wire IntegrationAbbott
Sep 2006 to Jun 2008
R&D Engineer, Drug Eluting StentsGuidant Corporation Basic company page — company details not listed yet
Jul 2001 to May 2006

Education

The Wharton School
MBA, Marketing and Entrepreneurship
2006 to 2008
Rose-Hulman Institute of Technology
BS, Chemical Engineering
1997 to 2001